Meet Our Experts at the World Vaccine Congress and Join Our Roundtable Discussion
ClinicalRM is a returning Bronze Sponsor at the 2017 World Vaccine Congress Washington (WVC), April 10-12 in Washington D.C. We look forward to seeing you at this exciting conference and we hope you’ll take the time to visit our booth (#16).
Additionally, Sr. Medical Advisor at ClinicalRM, Dr. Leslie Lobel, will be moderating a special roundtable discussion at WVC, Register here to join Dr. Lobel at WVC and engage in this discussion! Please note that seating is limited.on April 10th.
Dr. Lobel is also a member of the Department of Microbiology, Immunology and Genetics in the Faculty of Health Sciences at Ben Gurion University, and a member of the Department of Emerging and Reemerging diseases and Special Pathogens at the Uganda Virus Research Institute (UVRI) in Entebbe, Uganda. His work includes studies on the profile of the immune response to various viral diseases including Ebola Virus and Marburg Virus, CCHF, Foot and Mouth Disease Virus, and Arboviruses including the Flaviviruses and Zika. Dr. Lobel has been developing viruses as antiviral agents and is very well known for his non-standard way of solving scientific enigmas and developing new methodologies, many of which have been adapted by the U.S. Army, start-up companies and reference laboratories. He initiated several international programs in Central Africa in 2003 that are currently funded for work on EVD, MVD, and FMD.
Dr. Lobel’s FMD and Filovirus programs, awarded grants by the U.S. Department of Defense (DOD), USDA, ERC and NIH, are multi-million dollar grants for development of comprehensive control modalities for FMD and Filoviruses in Central Africa. For these large programs, and for developing significant field virology programs, he established an active laboratory in Uganda at the UVRI. Moreover, he has established strategic collaborations with the Gorgas Institute in Panama, Evandro Chagas Institute in Belem, Brazil and with the Fiocruz Institute in Salvador, Bahia, Brazil for studies of the immune response to Zika virus in different cohorts and populations of patients for vaccine development.
To request one-on-one meetings with our experts or for more information regarding our roundtable topic, please contact Amy Trotch, Marketing & Business Development Manager, at email@example.com.